Effects of Activity and Education Program on Patients With Chronic Hepatitis C Infection
- Conditions
- Hepatitis C Virus Infection, Response to Therapy of
- Interventions
- Behavioral: Personalized Physical Activity and Psycho-Education (PPAPE) Program
- Registration Number
- NCT01572233
- Lead Sponsor
- National Taiwan University Hospital
- Brief Summary
This 4-year project will be guided by a biobehavioral model for the study of exercise interventions in two phases with the purposes to :
1. explore the patients' physical activity preferences and develop doable activity lists during treatment period
2. examine the changes of health-related physical fitness component over interferon treatment
3. develop the Personalized Physical Activity and Psych-Education (PPAPE) Program and test its effects on decreasing fatigue, physical and psychological distress, and improving their health-related physical fitness and quality of life in patients with chronic hepatitis C receiving Interferon with Ribavirin Combination Therapy
4. evaluate the outcome of the PPAPE program on increasing adherence to therapy, the sustained virological response (SVR) in 24 weeks after the end of treatment, and the time-consuming for education program during intervention.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
- Patients with Chronic Hepatitis C Infection Receiving Interferon Therapy
- Aged above 18
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Patient with HCV Infection Personalized Physical Activity and Psycho-Education (PPAPE) Program Personalized Physical Activity and Psycho-Education (PPAPE) Program will be tested on this group.
- Primary Outcome Measures
Name Time Method Effects of Activity and Education Program on Patients with Chronic Hepatitis C Infection 4-year project Phase I of this project, the first and second year, the measurement time will be collected on the baseline (before treatment, T0), the 8 weeks (T1), 16 weeks (T2), and 24 weeks (T3) during treatment.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
National Taiwan University Hospital
🇨🇳Taipei, Taiwan